Signaturefd, LLC Mesoblast LTD Call Options Transaction History
Signaturefd, LLC
- $5.2 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MESO
# of Institutions
3Shares Held
151KCall Options Held
0Put Options Held
0About MESOBLAST LTD
- Ticker MESO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 147,316,000
- Market Cap $2.51B
- Description
- Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...